Metformin and breast cancer risk: a meta-analysis and critical literature review. - Wikidata - wikimedia - TriplyDB

Metformin and breast cancer risk: a meta-analysis and critical literature review.

Metformin and breast cancer risk: a meta-analysis and critical literature review.

http://www.wikidata.org/entity/Q34357389

about

Metformin and thyroid: an update Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review The association between type 2 diabetes mellitus and women cancer: the epidemiological evidences and putative mechanisms Targeting translation initiation in breast cancer Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis Medical prevention of breast cancer Impact of glucose-lowering agents on the risk of cancer in type 2 diabetic patients. The Barcelona case-control study Current strategies for the prevention of breast cancer Metformin and breast cancer stage at diagnosis: a population-based study Type 2 Diabetes Mellitus and Cancer: The Role of Pharmacotherapy.Glargine safety, diabetes and cancer.Metformin and breast and gynecological cancer risk among women with diabetes.Metformin enhances tamoxifen-mediated tumor growth inhibition in ER-positive breast carcinoma.Survival of patients with stage IV lung cancer with diabetes treated with metformin.Diabetes, diabetes treatment and breast cancer prognosis.Type 2 Diabetes and Breast Cancer: The Interplay between Impaired Glucose Metabolism and Oxidant Stress Treatment with insulin (analogues) and breast cancer risk in diabetics; a systematic review and meta-analysis of in vitro, animal and human evidence.Metformin therapy and prostate cancer risk: a meta-analysis of observational studies.Type 2 diabetes mellitus, oral diabetic medications, insulin therapy, and overall breast cancer risk Metformin use and young age lung cancer: A case series report Diabetes, metformin and incidence of and death from invasive cancer in postmenopausal women: Results from the women's health initiative.Association between metformin therapy and mortality after breast cancer: a population-based study.Comparative safety of diabetes medications and risk of incident invasive breast cancer: a population-based cohort study.Metformin use and endometrial cancer survival Diabetes, diabetes treatment, and mammographic density in Danish Diet, Cancer, and Health cohort.Obesity enhances nongenomic estrogen receptor crosstalk with the PI3K/Akt and MAPK pathways to promote in vitro measures of breast cancer progression Postmenopausal breast cancer, androgens, and aromatase inhibitors.Diabetes and cancer relationships.Beyond aspirin-cancer prevention with statins, metformin and bisphosphonates.Clinical studies examining the impact of obesity on breast cancer risk and prognosis.Treatment and outcomes in diabetic breast cancer patients.Sex and gender influences on pharmacological response: an overview.Relationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: a critical review.The expanding role of metformin in cancer: an update on antitumor mechanisms and clinical development.The association between metabolic health, obesity phenotype and the risk of breast cancer.Comparative Effect of Initiating Metformin Versus Sulfonylureas on Breast Cancer Risk in Older Women.Synergistic drug combinations from electronic health records and gene expression.No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: database analyses from Germany and the UK.The association between glucose-lowering drug use and mortality among breast cancer patients with type 2 diabetes.Metformin inhibition of neuroblastoma cell proliferation is differently modulated by cell differentiation induced by retinoic acid or overexpression of NDM29 non-coding RNA.

P2860

Q26822045-193D1036-4724-4ACF-837F-46FA462B61BC Q26850912-229C60DF-8896-4A20-9D0E-25172772313C Q27026813-E3B00817-23C6-486C-B8CD-96122A5BEABA Q27027284-EAF12193-F762-4E1E-A3B1-6D964C023575 Q28074225-C84CBE27-9D2E-4F4F-A0B4-EB4C418AA393 Q28086915-A5530ECE-40C5-4B8D-9A12-3B9BC4CEC2BB Q28535372-45DAD297-8091-4585-83D5-3461B3AB8F6F Q33599463-7048C1BB-59BC-4AD5-AAB3-812BCCB1F6D1 Q33611185-3AF3992A-D9C6-428D-9ED2-F9A8C7A9E481 Q33756414-E0462CFE-5A39-4916-A473-0EBF1EF3253F Q34326924-93EEF019-E7F9-4D30-80B8-8EBD7F9D03A8 Q35046074-71C08931-6E6B-4276-B1D8-8A41AAB45E6B Q35115554-4B8B8AC9-872F-43CF-8523-787115192C57 Q35153493-C1A17DD4-3F07-424B-BE8F-4B6E45E47C9E Q35373602-4377571E-F959-4CCD-938C-925C30523402 Q35782187-2CAF3C7E-23CE-4D3F-9303-29AFA7659472 Q35937961-D219BA36-E0BF-4863-AF26-2F00FEB29FF0 Q36182935-5B84F1D3-3D3B-451D-9112-FF245277A27F Q36582700-E08A0C86-4410-4436-ADC9-3544EFD3F8A7 Q36741232-D0B38DB5-A1B0-42E9-8ACE-BD02B2C27A38 Q36794283-38E3E01A-F68B-4A9A-9D87-5A8CCF926E49 Q37193432-DCBB6EE1-88D5-4812-9110-A28EABDF9CFA Q37228939-49CB4995-C170-497C-B0E2-E7B6A1CFA538 Q37523998-8C1877AD-4B3D-4EAB-93B2-02DFC5A80D12 Q37568800-9519887E-5283-4268-AC00-772E64E984F3 Q37690552-F07C9F87-F899-4619-A129-EDA5BCC28B7F Q38097730-E386FD8C-D35E-4599-8947-950F6C2913BB Q38097984-6C7F50A8-6848-46E3-A246-F56E47AFBE9D Q38147841-9780DE68-1CE4-4E1E-B207-F120BACB0FD7 Q38162118-3AC2CE5A-BC60-4DF2-A84E-A3D594C40EFC Q38180008-9C4794DE-A08B-46E8-9A11-EBAA14AE5D44 Q38214338-7160B20A-07E3-49C1-A418-5F536BB84754 Q38538492-7C328459-1FB3-4214-987F-78C9327E0F39 Q38728567-A855642A-8292-457D-9E1B-986A159154C9 Q38924489-80801128-DD3F-44C1-BEA7-A70B95C9A6DE Q38976502-414488C0-126E-4615-B658-747B4F1EBE22 Q39111678-6184D684-41AB-4F4B-BFC1-DFAF6508AE85 Q40778391-48B2D82F-0121-4E88-8D2D-017105E01F5A Q41241629-B1ED2E6D-DBBD-49E5-8CE2-7EE2FE01E3FE Q42019935-E4112222-FFA9-43A9-9249-1D2332D50D53

P2860

Metformin and breast cancer risk: a meta-analysis and critical literature review.

http://www.wikidata.org/entity/Q34357389

description

2012 nî lūn-bûn

@nan

2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Metformin and breast cancer risk: a meta-analysis and critical literature review.

@ast

Metformin and breast cancer risk: a meta-analysis and critical literature review.

@en

Metformin and breast cancer risk: a meta-analysis and critical literature review.

@nl

type

label

Metformin and breast cancer risk: a meta-analysis and critical literature review.

@ast

Metformin and breast cancer risk: a meta-analysis and critical literature review.

@en

Metformin and breast cancer risk: a meta-analysis and critical literature review.

@nl

prefLabel

Metformin and breast cancer risk: a meta-analysis and critical literature review.

@ast

Metformin and breast cancer risk: a meta-analysis and critical literature review.

@en

Metformin and breast cancer risk: a meta-analysis and critical literature review.

@nl

P1433

Q34357389-58681B96-2179-4A56-8477-9E4ED9D144DC

P1476

Q34357389-8CEC4D98-BFB8-4FE6-8B50-8F1D5A1CA4F5

P2093

Q34357389-07533509-685D-47B1-95F7-5998E21D938A

Q34357389-7DD026C1-3589-4444-BFF7-ACEC3FC4B854

Q34357389-C95C6A96-D235-4FDB-BC99-9AFB9BDEF173

Q34357389-E696E840-995E-4D20-ACC1-2315A0EEA7AB

Q34357389-F9202E4B-1276-488A-B000-039AB92772A3

P2860

Q34357389-039020A8-3BEE-425A-9E7E-DF697FBDBF37

Q34357389-1936266E-EFFD-4209-A33A-DC07CF21088E

Q34357389-2B10F54F-FCE8-4471-88DC-514C29C70A05

Q34357389-31A6D79C-78A9-4B97-837A-75C9D3D69F91

Q34357389-32648B2B-D9C0-478B-A0C5-BB6EBA2367EC

Q34357389-33CC2595-CB09-4FCE-95E9-A3AAE4011B61

Q34357389-36A4A142-DB54-4612-A03A-501797DD2FBF

Q34357389-3732B949-35CA-4333-AD85-B4A140DDA433

Q34357389-3CCCE793-E130-4537-B4EE-A3E942CF1FC6

Q34357389-499AC5D0-28AD-4CCF-B1D0-C85B90BE1885

P2888

Q34357389-D7AAB21A-A800-43B4-96DD-3C7636F0FF19

P304

Q34357389-00A9D02C-B34A-482E-82DE-7A1984193615

P31

Q34357389-5d3baabd-ae03-4207-9a0a-ef1ed27ed291

Q34357389-ABA5BAFB-2B4A-4E5D-BCF6-E8956A1329C2

P356

Q34357389-00730059-7901-4377-981B-9B2014AD762F

P407

Q34357389-30574688-A28E-4861-B42D-8384B55420EF

P433

Q34357389-C9B06451-1B08-4721-AD60-0EDE4808BB8D

P478

Q34357389-47A7B8AF-63FB-4659-B289-118CBCF02F55

P577

Q34357389-A04C2749-05DA-4F2D-8412-980D97348AB1

P5875

Q34357389-2F1E7223-4E92-4FB1-B09D-5C1D79AC1A04

P6179

Q34357389-491FE431-F75C-4196-8EE3-CA162DE0F2B4

P698

Q34357389-BA1B5CDC-1E59-437B-ADF1-C3CAE5345573

P921

Q34357389-94B361CD-AD53-47F5-B2B2-EA3D25370247

Q34357389-B70F64D1-56C0-4A9E-97B4-104F86BEA37F

P356

S10549-012-2170-X

P1433

Breast Cancer Research and Treatment

P1476

Metformin and breast cancer risk: a meta-analysis and critical literature review.

@en

P2093

Aaron K Aragaki

http://www.w3.org/2001/XMLSchema#string

Leslie Ochs

http://www.w3.org/2001/XMLSchema#string

Nananda F Col

http://www.w3.org/2001/XMLSchema#string

Rowan T Chlebowski

http://www.w3.org/2001/XMLSchema#string

Vicky Springmann

http://www.w3.org/2001/XMLSchema#string

P2860

Role of AMP-activated protein kinase in mechanism of metformin action

Metformin in cancer: translational challenges

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies

GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias)

Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer

Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis.

Metformin: a therapeutic opportunity in breast cancer.

Long-term metformin use is associated with decreased risk of breast cancer.

Experience of malignancies with oral glucose-lowering drugs in the randomised controlled ADOPT (A Diabetes Outcome Progression Trial) and RECORD (Rosiglitazone Evaluated for Cardiovascular Outcomes and Regulation of Glycaemia in Diabetes) clinical t

P2888

s10549-012-2170-x

P304

639-646

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10549-012-2170-X

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

135

http://www.w3.org/2001/XMLSchema#string

P577

2012-07-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230589161

http://www.w3.org/2001/XMLSchema#string

P6179

1022720204

http://www.w3.org/2001/XMLSchema#string

P698

22847511

http://www.w3.org/2001/XMLSchema#string

P921